首页|增强MRI联合IVIM-DWI诊断小肝细胞癌价值研究

增强MRI联合IVIM-DWI诊断小肝细胞癌价值研究

扫码查看
目的 探讨增强磁共振(MRI)联合体素内不相干运动磁共振扩散加权成像(IVIM-DWI)诊断小肝细胞癌(sHCC)的价值。方法 2020 年5 月~2023 年5 月我院收治的肝脏局灶性病变患者 73 例,所有患者均接受增强MRI和IVIM-DWI检查,观察病灶增强强化信号特点,分析病灶IVIM-DWI定量参数,即伪扩散系数(D∗)、真实扩散系数(D)和灌注分数(f)。采用细针穿刺或取术后组织行病理学检查。应用受试者特征工作曲线(ROC)下面积(AUC)评估增强MRI联合IVIM-DWI诊断sHCC的效能。结果 经病理学检查,在73 例肝脏局灶性病变患者中,诊断sHCC者49 例(67。1%)和肝脏异型性增生结节(DN)者24 例(32。9%);sHCC病灶T1WI低信号、T2WI高信号、动脉期强化和肝胆期低信号占比分别为61。2%、83。7%、59。2%和89。8%,均显著高于DN病灶的20。8%、33。3%、25。0%和29。2%(P<0。05);sHCC病灶D∗和D分别为(50。9±11。6)×10-3mm2/s和(0。8±0。2)×10-3mm2/s,均显著小于DN病灶[分别为(78。4±15。8)×10-3mm2/s和(1。2±0。3)×10-3mm2/s,P<0。05],而两组f比较,差异无统计学意义[分别为(45。6±8。7)%对(43。9±9。5)%,P>0。5];ROC分析表明,应用T1WI信号、T2WI信号、动脉期强化、肝胆期信号、D∗和D联合诊断sHCC的AUC为0。968,其灵敏度和特异度分别为100。0%和86。0%。结论 应用增强MRI和IVIM-DWI联合诊断sHCC的效能较高,可为临床诊疗提供有益的依据,值得进一步深入研究。
Contrast-enhanced MRI and IVIM-DWI in the diagnosis of patients with small hepatocellular carcinoma
Objective The aim of this study was to explore the diagnostic performance of contrast-enhanced magnetic resonance imaging(MRI)and intravoxel incoherent motion-diffusion weighted imaging(IVIM-DWI)in patients with small hepatocellular carcinoma(sHCC).Methods 73 patients with focal nodular hyperplasia(FNH)were enrolled in our hospital between May 2020 and May 2023,and all patients underwent contrast-enhanced MRI and IVIM-DWI,recording the pseudo diffusion coefficient(D∗),true diffusion coefficient(D)and perfusion fraction(f).The fine needle aspiration biopsies or postoperative histopathology were performed for golden diagnosis.The diagnostic efficacy of contrast-enhanced MRI and IVIM-DWI was evaluated by receiver operating characteristic(ROC)curves.Results Among the 73 patients with FNH,the histopathology examination showed sHCC in49 cases(67.1%)and the dysplastic nodules(DN)in 24 cases(32.9%);the percentages of low signals on T1WI,high signals on T2WI,arterial phase enhancement and low signals during hepatobiliary phase in HCC lesions were 61.2%,83.7%,59.2%and 89.8%,all significantly higher than 20.8%,33.3%,25.0%and 29.2%(P<0.05)in DN lesions;the D∗ and D in HCC lesions were(50.9±11.6)×10-3mm2/s and(0.8±0.2)×10-3mm2/s,both significantly less than[(78.4±15.8)×10-3mm2/s and(1.2±0.3)×10-3mm2/s,P<0.05]in DN lesions,while there was no significant difference as respect to f between the two lesions[(45.6±8.7)%vs.(43.9±9.5)%,P>0.5];the ROC analysis showed the AUC was 0.968,with the sensitivity of 100.0%and the specificity of 86.0%,when the T1WI and T2WI signals,arterial phase enhancement,hepatobiliary phase signal,D∗ and D was combined for the diagnosis of sHCC.Conclusion The contrast-enhanced MRI and IVIM-DWI are efficacious in the diagnosis of patients with sHCC,which might provide the clinicians a reliably tool for early differentiation of patients with FNH.

HepatomaDysplastic nodulesContrast-enhanced magnetic resonance imagingIntravoxel incoherent motion-diffusion weighted imagingDiagnosis

夏礼鹏、褚玉玄、赵如盛

展开 >

210029 南京市 南京医科大学第一附属医院放射科

小肝细胞癌 肝脏异型性增生结节 磁共振成像 体素内不相干运动磁共振扩散加权成像 诊断

江苏省卫生健康委科研项目

BJ2021015

2024

实用肝脏病杂志
中华医学会安徽分会

实用肝脏病杂志

CSTPCD
影响因子:1.362
ISSN:1672-5069
年,卷(期):2024.27(4)